| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/07/2000 | CA2374402A1 Biosynthesis of foreign proteins using transformed microalgae |
| 12/07/2000 | CA2374391A1 Mammalian receptor proteins; related reagents and methods |
| 12/07/2000 | CA2374387A1 Adipocyte complement related protein homolog zacrp7 |
| 12/07/2000 | CA2374376A1 Lipid metabolism transcription factor |
| 12/07/2000 | CA2374347A1 Screening method for peptides |
| 12/07/2000 | CA2374310A1 Nutritional supplements |
| 12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
| 12/07/2000 | CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
| 12/07/2000 | CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth |
| 12/07/2000 | CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
| 12/07/2000 | CA2373706A1 Fibrin sealants providing less inflammatory response and methods using same |
| 12/07/2000 | CA2373704A1 Prevention of post surgical adhesions using a fibrin monomer sealant |
| 12/07/2000 | CA2373638A1 Adam polynucleotides and polypeptides |
| 12/07/2000 | CA2373635A1 Method of producing submicron particles of a labile agent |
| 12/07/2000 | CA2373547A1 Methods for induction of tolerance to adenoviral vectors and transgene products |
| 12/07/2000 | CA2373047A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 12/07/2000 | CA2372566A1 Modified cytokine for its stabilisation |
| 12/07/2000 | CA2372250A1 Fimbrial proteins |
| 12/07/2000 | CA2372249A1 Chemokine receptor ccr3 antagonists |
| 12/07/2000 | CA2372246A1 Human tumor necrosis factor receptor tr10 |
| 12/07/2000 | CA2372242A1 Virus immunologic determinants |
| 12/07/2000 | CA2372234A1 Oxazaheterocycles as protease inhibitors |
| 12/07/2000 | CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 12/07/2000 | CA2371247A1 Substantially oil-free cyclosporin compositions |
| 12/07/2000 | CA2370311A1 Prevention and treatment of amyloidogenic disease |
| 12/07/2000 | CA2336262A1 Sorting nexins |
| 12/06/2000 | EP1058117A1 Use of SLIM3 to bind to molecules |
| 12/06/2000 | EP1057895A1 Fusion protein comprising Shiga toxin 2e B subunit, (vaccine)compositions comprising it, and methods for their production |
| 12/06/2000 | EP1057491A1 Preventives/remedies for skin aging |
| 12/06/2000 | EP1057490A2 Use of tranexamic acid for the preparation of a human fibrinogen composition |
| 12/06/2000 | EP1057489A1 Preventives or remedies for ischemic diseases |
| 12/06/2000 | EP1057035A2 Method for detecting intimin producing microorganisms |
| 12/06/2000 | EP1057026A1 Circulating insulin-like growth factor-i and prostate cancer risk |
| 12/06/2000 | EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 12/06/2000 | EP1056878A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 12/06/2000 | EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 12/06/2000 | EP1056871A1 Cprot03, a human cysteine protease |
| 12/06/2000 | EP1056869A2 Cell cycle related proteins |
| 12/06/2000 | EP1056865A2 Leptospiral outer membrane protein, lipl32 |
| 12/06/2000 | EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 12/06/2000 | EP1056859A1 High affinity humanized anti-cea monoclonal antibodies |
| 12/06/2000 | EP1056857A2 Transporter for saccharide-coupled medicaments |
| 12/06/2000 | EP1056856A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 12/06/2000 | EP1056854A2 Protease-activated receptor 4 and uses thereof |
| 12/06/2000 | EP1056853A2 Human channel-related molecules |
| 12/06/2000 | EP1056851A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72 |
| 12/06/2000 | EP1056850A2 Biotin-binding receptor molecules |
| 12/06/2000 | EP1056849A1 Human smn-like protein |
| 12/06/2000 | EP1056848A1 Human protein kinase c inhibitor |
| 12/06/2000 | EP1056846A1 Cerebellin-2 related polypeptides and dna coding therefor |
| 12/06/2000 | EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 12/06/2000 | EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14 |
| 12/06/2000 | EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 12/06/2000 | EP1056839A1 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 12/06/2000 | EP1056835A1 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
| 12/06/2000 | EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 12/06/2000 | EP1056780A1 Method of producing mouse and human endostatin |
| 12/06/2000 | EP1056779A1 Method for producing a factor viii/von willebrand factor complex |
| 12/06/2000 | EP1056778A1 G protein-coupled receptor antagonists |
| 12/06/2000 | EP1056777A1 Ligand receptors and uses therefor |
| 12/06/2000 | EP1056776A1 Methods for treatment of diabetes using peptide analogues of insulin |
| 12/06/2000 | EP1056775A1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| 12/06/2000 | EP1056774A1 N-terminally truncated glp-1 derivatives |
| 12/06/2000 | EP1056772A2 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them |
| 12/06/2000 | EP1056771A1 Streptogramin derivatives, preparation method and compositions containing same |
| 12/06/2000 | EP1056770A1 Novel disulfides and thiol compounds |
| 12/06/2000 | EP1056764A1 Secreted proteins and polynucleotides encoding them |
| 12/06/2000 | EP1056762A1 Genetic immunization with nonstructural proteins of hepatitis c virus |
| 12/06/2000 | EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 12/06/2000 | EP1056760A1 36 human secreted proteins |
| 12/06/2000 | EP1056722A1 Bisulfate salt of hiv protease inhibitor |
| 12/06/2000 | EP1056704A1 Antitumor agents |
| 12/06/2000 | EP1056474A2 Affinity markers for human serum albumin |
| 12/06/2000 | EP1056472A2 Specific antibodies against mammary tumor-associated mucin, method for production and use |
| 12/06/2000 | EP1056471A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS |
| 12/06/2000 | EP1056469A1 Novel peptide copolymer compositions |
| 12/06/2000 | EP1056468A1 Method of promoting embryonic stem cell proliferation |
| 12/06/2000 | EP1056467A2 Method for the treatment of diseases or disorders of the inner ear |
| 12/06/2000 | EP1056465A1 Antimicrobial peptides and derived metapeptides |
| 12/06/2000 | EP1056459A1 Treatment of hiv infections |
| 12/06/2000 | EP1056413A1 Injectable implants for tissue augmentation and restoration |
| 12/06/2000 | EP1056357A1 Calorically dense nutritional composition |
| 12/06/2000 | EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 12/06/2000 | EP0777458B1 Control of hair growth |
| 12/06/2000 | EP0675733B1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 12/06/2000 | CN1276011A Keratinocyte derived protease |
| 12/06/2000 | CN1275917A Potentiator for antibody against lymphoid tumor |
| 12/06/2000 | CN1275916A Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 12/06/2000 | CN1275912A Novel amide derivatives |
| 12/06/2000 | CN1275906A Plaque-inhibiting oral compositions |
| 12/06/2000 | CN1275576A Human urine anti-tumor (antibacterial) peptide, its preparation and use |
| 12/06/2000 | CN1275408A Technology for preparation of biological dressing material |
| 12/06/2000 | CN1059237C Method for producing recombined human liver cytokinin and its use for curing serious hepatic disease |
| 12/06/2000 | CN1059214C Cellulose binding domain |
| 12/06/2000 | CN1059127C Process for preparation of Shuganmei medicine for treating liver disease |
| 12/05/2000 | US6156888 Mixture of a carrier and a polynucleotide encoding a hybrid protein of a factor viii protein having an acidic region from a donor anticoagulant or antithrombotic protein replacing a region in the native protein |
| 12/05/2000 | US6156887 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/05/2000 | US6156882 Monoclonal antibody which binds specifically to human tyrosine kinase receptor flt3/flk2 protein; early diagnosis of hematopoietic tumors and leukemias; antitumor agents |
| 12/05/2000 | US6156881 Inhibition of cell adhesion protein-carbohydrate interactions |
| 12/05/2000 | US6156879 Human minor vault protein p193 |